Search Orphan Drug Designations and Approvals
-
Generic Name: | Dehydroepiandrosterone (DHEA) |
---|---|
Date Designated: | 08/19/2003 |
Orphan Designation: | Replacement therapy in individuals with adrenal insufficiency |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Paladin Labs, Inc. 6111 Royalmount Avenue, Suite 102 Montreal Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-